Research Article |
Corresponding author: May Mohammed Jawad Al-Mudhafar ( may.mj.almudhafar@copharm.uobaghdad.edu.iq ) Academic editor: Alexander Zlatkov
© 2024 May Mohammed Jawad Al-Mudhafar, Jaafar Suhail Wadi.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Al-Mudhafar MMJ, Wadi JS (2024) Synthesis and biological activity evaluation of new isatin-gallate hybrids as antioxidant and anticancer agents (in vitro) and in silico study as anticancer agents and coronavirus inhibitors. Pharmacia 71: 1-11. https://doi.org/10.3897/pharmacia.71.e124992
|
Background: The hybrid compounds hold promise for developing novel pharmaceuticals, potentially exhibiting greater activity, mainly against viruses and cancer diseases, than their components.
Objective: In this study, researchers explored the potential synergistic effects of hybrid molecules by designing and synthesizing a series of isatin-gallate hybrids, denoted as N’-(5-substituted-2-oxoindolin-3-ylidene)-3,4,5-trihydroxybenzohydrazide (3a–d).
Methods: Isatin-gallate hybrids (3a–d) were synthesized by reacting gallic hydrazide with each of the isatin analogs (2a–d). The structures of all produced compounds were described using spectrum methods such as fourier transform infrared (FTIR), 1H-nuclear magnetic resonance spectroscopy (1H-NMR), and physicochemical attributes. The evaluation of the tested hybrids (3a–d) involved assessing their in vitro antioxidant activities using the α, α-diphenyl-β-picrylhydrazyl (DPPH) free radical scavenging method and cytotoxic activities through the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] colorimetric assay for measuring cellular growth. Furthermore, in silico analysis was applied to the final hybrids to evaluate their effects as anticancer and anti-coronavirus agents.
Conclusion: Among the examined hybrid compounds, 3b demonstrated substantial in vitro antioxidant and cytotoxic activities. In silico analysis revealed slight variations in the anticancer activity of compounds 3a–d, with differing affinities observed across various cancer cell lines. Additionally, these compounds exhibited moderate efficacy in inhibiting coronavirus activity.
anticancer, anti-coronavirus, antioxidant, isatin-gallolyl hybrids, in silico
The synthesis of hybrid molecules by combining many pharmacophores in one structure may result in compounds with remarkable pharmacological properties while designing new medications. Many anticancer drugs already on the market have poor enough selectivity against cancer cells, which can have a variety of harmful side effects (
Medications derived from natural sources and their derivatives efficiently treat and prevent diseases. Polyphenol compounds like gallic acid are among the most important natural sources. Propyl gallate, a propyl ester of gallic acid, is an important semi-synthetic compound. It is prepared either biologically (enzymatically) or chemically (
Dietary phenolic extracts were highly dependent on their structural properties, which, in turn, established their antioxidant and anticancer activities (
Gallic hydrazide Schiff bases were synthesized and evaluated for their antioxidant activities by Gwaram et al. (
The indole nucleus has attracted scientists to develop new compounds; they are biologically essential chemicals and possess different biological activities (
The combination of gallic acid and curcumin inhibited the growth of MDA-MB-231 breast cancer cells (
The scientists designed many isatin derivatives and/or hybrids with other active molecules; for example, five isatin hydrazone Schiff bases connected to the acetylenic moiety have been synthesized by Singh et al. (
A series of β-Isatin aldehyde-N, N’-thiocarbohydrazone derivatives were synthesized and assayed for their in vitro antioxidant activity. The new derivatives with p-chlorophenyl substitution are the most effective antioxidants against DPPH and H2O2 scavenging activity and exhibit the highest antimicrobial activity (
Furthermore, El-Serwy et al. investigated the antioxidant, anticoagulant, and fibrinolytic activity of some new isatin hydrazone-hydrazide derivatives, and most of these compounds showed potent antioxidant activity (
Tumosien et al. reported on the synthesis of numerous compounds containing one or two 2-oxindole-hydrazone moieties in addition to evaluations of their antioxidant and anticancer activity after comparing the colon adenocarcinoma HT-29 cell line, which appeared to be more responsive to treatment with the hydrazone-isatin derivatives than the malignant melanoma A375 cell line. Also, it was found that bis(hydrazone-isatins) were more active than their monoforms (
Chen et al. prepared a group of N-substituted isatin derivatives; their SARS-COV protease inhibitory effect was attributed to the isatin derivatives at C5 having electron-withdrawing groups such as NO2, Br, and I, with N1 holding the benzothiophene methyl group (
Due to the synergistic effect, hybrid molecules may have greater activity than each component when designing new medications. In this research, the hybridization of gallic acid and various isatin analogs may provide new candidates with diverse biological activities, such as antioxidant and anticancer agents. Moreover, molecular docking was applied for anticancer and anti-coronavirus activities for future studies; however, experimental validation is necessary to confirm the inhibitory effect of these compounds as coronavirus inhibitors. In this study, researchers explored the potential synergistic effects of hybrid molecules by designing and synthesizing a series of isatin-gallate hybrids, denoted as N’-(5-substituted-2-oxoindolin-3-ylidene)-3,4,5-trihydroxybenzohydrazide (3a–d).
An electronic melting point apparatus named the Stuart SMP30 was used to determine the melting points (uncorrected). An FTIR spectrophotometer from Shimadzu, Japan, was used to record the FT-IR spectra, with support from Specac® Quest ATR (diamond)-UK.1H‒NMR spectra were determined in deuterated dimethylsulphoxide (DMSO-d6); the chemical shifts were reported in δ (ppm). The NMR ultra-shield spectrophotometer, 500 MHz, was conducted at Tehran University (
Visualization was demonstrated using the UCSF chimera tool version 1.17.3 (University of California San Francisco, San Francisco, United States) and studio discovery software version 4.5 (BIOVIA). The binding site was determined based on the already existing native ligand.
In a round boiling flask (0.02 mole, 3.96 g), propyl gallate (obtained from Hangzhou Hyper Chemicals Limited, LOFT49 Hangzhou, China) was added to (0.2 mole, 10 mL) 99% hydrazine hydrate (NH2-NH2) diluted in 60 mL of ethanol; this mixture was refluxed for 15 hours as shown in Fig.
An appropriate isatin analog from 2a–d (0.003 mol) was added separately to (0.003 mol) of compound 1 (Fig.
Yellow-colored powder of 85% yield. M.p. 293–295 °C; IR (υ cm-1): 3506 (O-H, phenol), 3263, 3209 (N-H, amide), 1693, 1651 (two C=O, amide groups), 1603 (C=N, imine, overlap with aromatic C=C conjugation); 1H--NMR δ ppm: 13.79 (s, NH of hydrazide, 1H), 11.34 (s, NH of amide, 1H), 9.00 (s, OH of phenol, 1H), 9.46 (s, OH of phenol, 2H), 6.91–7.60 (m, Ar-H, 6H) the HNMR result illustrated in Fig.
Reddish brown-colored powder of 88% yield. M.p. 284 °C; IR (υ cm-1): 3618 (O-H, phenol), 3201, 3174 (N-H, amide), 2860 (CH3, -OCH3 group), 1693 and 1666 (two C=O, amide groups), 1605 (C=N, imine, overlap with aromatic C=C conjugation); 1H-NMR δ ppm: 13.83 (s, NH of hydrazide, 1H), 11.13 (s, NH of amide, 1H), 9.10 (s, OH of phenol, 1H), 9.43 (s, OH of phenol, 2H), 6.85–7.11 (m, Ar-H, 5H), 3.74 (s, O-CH3, 3H) the HNMR result illustrated in Fig.
Greenish-yellow-colored powder with a 71% yield. M.p. 325–327 °C; IR (υ cm-1): 3429 (O-H, phenol), 3251, 3197 (N-H, amide), 1697, and 1654 (two C=O, amide groups), 1608 (C=N, imine, overlap with aromatic C=C conjugation); 1H-NMR δ ppm: 13.72 (s, NH of hydrazide, 1H), 11.45 (s, NH of amide, 1H), 9.10 (s, OH of phenol, 1H), 9.47 (s, OH of phenol, 2H), 6.92–7.66 (m, Ar-H, 5H) the HNMR result illustrated in Fig.
Orange-colored powder with a 77% yield. M.p. 337–340 °C; IR (υ cm-1): 3556 (O-H, phenol), 3186, 3066 (N-H, amide), 1693 and 1654 (two C=O, amide groups), 1608 (C=N, imine, overlap with aromatic C=C conjugation); 1H-NMR δ ppm: 13.80 (s, NH of hydrazide, 1H), 11.35 (s, NH of amide, 1H), 9.33 (s, OH of phenol, 1H), 9.44 (s, OH of phenol, 2H), 6.89–7.42 (m, Ar-H, 5H).
The antioxidant activity was investigated in terms of free radical scavenging activity by the scavenging activity of 2,2-diphenyl-1-picrylhydrazyl (DPPH): The free radical scavenging activity of four different hybrids in various concentrations was measured by a 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. Briefly, a solution of DPPH at 0.1 mM in ethanol was prepared. A total of 190 μl of DPPH solution (0.1 mL) was added to 10 μl of each derivative in various concentrations (200, 100, 50, 25, 12.5 μg/mL) in DMSO. DMSO was used as a blank. The plate was shaken vigorously and kept at room temperature for 30 min. DPPH solution has a deep violet color, with the highest absorbance at 517 nm (
% of inhibition or DPPH scavenging effect = [A0–A1/A0] × 100
Where A0 is the absorbance of the control, A1 is the absorbance of the sample.
Cell cultures and cell maintenance were applied in a humid environment; MCF-7, HeLa, HCT116, and WRL-68 cells were cultured using RPMI-1640 media enhanced with 10% fetal bovine serum and 1% penicillin-streptomycin antibiotic and incubated at 37 °C in a CO2 (5%) incubator. Sub-cultured cells were loaded at a density of around 4 × 105 cells/mL. The cells were subcultured into new cell culture dishes as needed for the experiment as soon as they reached 80–90% confluency (
The cell growth inhibition effects of serial dilutions (25, 50, 100, 200, and 400 µg/mL) of compounds 3a, 3b, 3c, and 3d were detected by a colorimetric MTT assay. A fully confluent monolayer sheet was formed by seeding 1×105 cells per well in a 96-well microtiter plate and allowing it to proliferate for 24 h at 37 °C using a CO2 (5%) incubator. After incubation, fresh media was added, and cells were treated with compounds 3a, 3b, 3c, and 3d at desired concentrations for another 24 h. Following the treatment period, cells were washed with sterile phosphate buffered saline (PBS), and 20 µL of MTT solution (5 mg/mL in PBS) were added in each well and maintained for a further 4 h at 37 °C and 5% CO2, with regular monitoring for the formation of blue-colored formazan crystals under an inverted microscope. To solubilize the formazan crystals (MTT metabolic product), 200 µl of DMSO were added to each well after the medium in the plates was removed. At 560 nm, optical density was observed using a plate reader (Bio-Rad, Germany). The MTT assay was conducted using previously described methods (
Cell viability (%) = Sample A560/Control A560 × 100%
The crystal structure of epidermal growth factor receptor EGFR and RNA polymerase was retrieved from the protein data bank PDB (website: https://www.rcsb.org/). The PDB codes were 1M17 for EGFR and 7AAP for RNA polymerase. All water, ions, and ligands were removed before docking, and both proteins were energetically minimized by 500 steepest descent minimization steps. The protein is prepared for docking by adding the charges (AMBER ff14SB force field) and hydrogens. The ligands were sketched by ChemOffice and minimized by the MM2 force field. AutoDock Vina was used for docking after the validation process (Fig.
The synthetic route for target compounds (isatin-galloyl hybrids) is presented in Fig.
Structural interpretation confirmed by FT-IR spectra of compounds 3a–d revealed the presence of -C=N- absorptions (at wavenumbers of 1603, 1605, 1608, and 1608 cm−1, respectively), confirming the formation of imines. The broad bands observed in the range (3429–3618 cm−1) were attributed to the phenolic -OH groups. The 1H-NMR spectra of the isatin-galloyl hybrids (3a–d) implied singlet signals at δ 13.79, 13.83, 13.72, and 13.80 ppm, respectively, correspond to (-CO-NH-) of hydrazide groups; other singlet signals detected at δ 11.34, 11.13, 11.45, and 11.35 ppm correspond to the -CO-NH- amide groups of the isatin part. Moreover, compound 3b displayed a singlet signal at 3.74, which was attributed to the methoxy group.
A DPPH radical-scavenging experiment was used to evaluate the antioxidant activity of the produced compounds. The outcomes were contrasted with those of ascorbic acid (Table
The percentage of DPPH radical scavenging activity in different concentrations.
Compounds | Scavenging activity% (Mean ± SD) | ||||
---|---|---|---|---|---|
Concentrations | |||||
200µg/mL | 100 µg/mL | 50 µg/mL | 25 µg/mL | 12.5 µg/mL | |
Ascorbic acid | 80.73 ± 1.87 | 72.73 ± 1.61 | 57.6 ± 2.2 | 39.0 ± 1.73 | 22.9 ± 1.83 |
3a | 76.3 ± 3.80 | 63.4 ± 3.22** | 54.09 ± 2.11 | 46.6 ± 6.19* | 32.8 ± 2.93** |
3b | 76.77 ± 4.05 | 67.34 ± 0.72 | 55.67 ± 1.44 | 28.27 ± 4.60** | 21.49 ± 5.32 |
3c | 76.54 ± 3.30 | 62.08 ± 1.01** | 52.74 ± 3.14 | 39.62 ± 4.13 | 27.7 ± 1.35 |
3d | 44.02 ± 8.54** | 34.92 ± 1.96** | 22.03 ± 7.65** | 17.21 ± 3.02** | 14.54 ± 2.68 |
The cytotoxicity of all the synthesized compounds (3a–d) was evaluated against HeLa, MCF-7, and HCT116 tumor cell lines using the MTT method. The cytotoxic potential of compounds 3a, 3b, 3c, and 3d was investigated using an MTT assay against the breast cancer cell line MCF-7 cells. According to Table
Cytotoxic activities of compounds (3a, 3b, 3c, and 3d) in human cancer (MCF-7, HeLa, and HCT116) and normal cells (WRL-68) in vitro (IC50 µg/mL) after 24 hours of incubation.
Compound | Half-Maximal Inhibitory Concentration (IC50) % in µg/mL | |||
---|---|---|---|---|
MCF-7 | HeLa | HCT116 | WRL-68 | |
3a | 123.5 | 105.0 | 76.27 | 301.8 |
3b | 114.9 | 155.5 | 175.26 | 231.3 |
3c | 174.4 | 163.3 | 147.6 | 200.6 |
3d | 164.8 | 161.1 | 112.6 | 206.4 |
Mean ± SD cell viability after treatment with compounds 3a, 3b, 3c, and 3d using an MTT in vitro assay at 37 °C. A. Shows the MCF-7 cell viability %; B. Cell viability of HeLa cells; C. SD cell viability of HCT116 cells. Different letters (a, b, and c) are considered significant (p < 0.05). NS: non-significant; SD: standard deviation; n = 3.
Compounds 3a, 3b, 3c, and 3d were tested for their anticancer potentials in HeLa cells. Results in Fig.
Collectively, based on Table
The anticancer efficacy of gallic acid was highly dependent on its structural properties, which, in turn, established its anticancer and antioxidant activities (
The results will include the binding affinity of the compounds toward the proteins, which is represented by the binding energy that was scored using box grid-based docking software (Table
EGFR | |
Erlotinib | -6.9 |
Compound 3a | -8.4 |
Compound 3b | -8.1 |
Compound 3c | -7.8 |
Compound 3d | -8.5 |
SARS-CoV2 RNA-dependent RNA polymerase | |
RTP-favipiravir | -9.2 |
Compound 3a | -6.99 |
Compound 3b | -6.7 |
Compound 3c | -5.85 |
Compound 3d | -6.42 |
The docking results presented in this study provide valuable insights into the binding affinities of four compounds, namely 3a, 3b, 3c, and 3d, compared to the reference compound Erlotinib (Fig.
The docking results presented in this study offer valuable insights into the binding affinities of four compounds, namely 3a, 3b, 3c, and 3d, compared to the reference compound RTP-favipiravir (Figs
Notably, RTP-favipiravir, the reference compound, displayed the highest binding affinity with a docking score of (-9.2), underscoring its strong interaction with RNA polymerase. In contrast, hybrid compounds 3a, 3b, 3c, and 3d exhibited lower docking scores, suggesting less favorable binding affinities compared to RTP-favipiravir.
All investigated substances had observable DPPH radical scavenging action compared to the reference molecule (ascorbic acid), which had an IC50 (oxidative stress inhibitory concentration 50%) value of 26.35 µg/mL. Among them, compound 3b with the methoxy group at position 5 of the isatin motif showed the highest activity. Compound 3a of the unsubstituted isatin motif part was the next strength, with an IC50 value of 51.09 µg/mL. The halogenated compounds, 3c bearing (bromo group) and 3d bearing (fluoro group), showed the lowest inhibitory activity, with IC50 values of 52.29 and 187.6 µg/mL, respectively. Introducing an -OCH3 group in position 5 of the isatin motif significantly enhances the antioxidant activity. This might be explained by the methoxy group’s electron-donating characteristics, which increase the likelihood of an electron transfer from the lone pair electron on the isatin nitrogen atom by resonance. This research about the antioxidant effect has come in line with other studies published related to our compounds; research conducted on 3,4,5-trihydroxyphenylacetamide, which is very near compound 3a, shows that it was discovered that there was no direct relationship between anti-peroxidation and radical scavenging capabilities (
Depending on IC50, MCF-7 cells showed the highest sensitivity in cell viability to compound 3b in a dose-dependent fashion, with an IC50 value of 114.9 µg/mL. The recorded IC50s of compounds 3a, 3c, and 3d in MCF-7 cells were 123.5, 174.4, and 164.8 µg/mL, respectively. On the other hand, all compounds revealed weak to moderate toxicity against the normal cells of WRL-68 with an IC50 range of 200–300 µg/mL (Table
Several studies concluded that gallic acids have good antitumor action; however, this has drawn the most attention. It has been shown to have anticancer properties in various cancer cells. It is believed that hybrid pharmaceuticals, which combine several prescriptions, may be able to stop or postpone the development of treatment resistance in cancer patients (
Firstly, it is evident that all four compounds exhibited superior docking scores compared to Erlotinib. Compound 3a displayed the highest binding affinity with a docking score of (-8.4), followed closely by compound 3d with a score of (-8.5). This suggests that these compounds have a strong potential for effectively binding to the EGFR active site, outperforming Erlotinib, which had a docking score of (-6.9).
The shared structural features among compounds 3a, 3b, 3c, and 3d, which include isatin, hydrazine, and trihydroxyphenyl moieties, may play a significant role in their enhanced binding affinity. These structural elements are distinct from Erlotinib’s quinazoline and anilino groups. These variations suggest that isatin, hydrazine, and trihydroxyphenyl groups in these compounds may contribute to their increased binding affinity. These structural variations could enhance the interaction with key residues in the EGFR binding pocket.
Small changes, such as the addition of a fluorine atom in 3d and a bromine atom in 3c, could, however, be responsible for the higher binding affinity. These structural changes may improve the interaction with important residues in the EGFR binding pocket (
RTP-favipiravir, the reference compound, displayed the highest binding affinity with a docking score of (-9.2), underscoring its strong interaction with RNA polymerase. In contrast, hybrid compounds 3a, 3b, 3c, and 3d exhibited lower docking scores, suggesting less favorable binding affinities compared to RTP-favipiravir.
The chemical structures of these compounds significantly influence their binding affinities. RTP-favipiravir possesses a unique structure optimized for RNA polymerase inhibition, which explains its superior binding. Compounds 3a, 3b, 3c, and 3d share a common structural motif, which includes isatin, hydrazine, and trihydroxyphenyl moieties. While these structural elements differ from RTP-favipiravir, they may not be as tailored to RNA polymerase inhibition.
The observed differences in binding affinities highlight the importance of structural optimization for effectively targeting RNA polymerase. While compounds 3a, 3b, 3c, and 3d may exhibit moderate binding affinities, further structural modifications and optimization are likely necessary to enhance their potential as RNA polymerase inhibitors (
Additionally, it is important to consider that docking scores provide insights into the theoretical binding strength; however, experimental validation is essential to confirm the inhibitory activity of these compounds against RNA polymerase.
Throughout all these years, a wide variety of research has been carried out using isatin derivatives, which has resulted in the synthesis of a new series of isatin-gallate hybrids. The in vitro study exhibited that the hybrids showed promising activity against MCF7 cell lines. The hybrids showed less toxic effects on normal cells, which indicated that the hybrids are selective against cancer cells. Antioxidant activity screening showed that the hybrids exhibited moderate to good activity, as evidenced by the reducing power and free radical scavenging activity towards DPPH. The structure-activity relationship could be constructed, indicating that the cytotoxic activity of the hybrids may be due to the presence of the isatin and gallate moiety. Additionally, an in silico analysis assessed their anticancer and anti-coronavirus properties. The isolated derivatives were characterized using FT-IR and 1H- NMR spectral data. Results from biological activity assays indicated varied in vitro antioxidant potencies among the substituted hybrids, with the most potent being hybrid (3b) containing the -OCH3 group. For in vitro anticancer activity, hybrid (3b) also emerged as the most potent. Molecular docking studies highlighted the fluoro-substituted isatin-gallolyl hybrid (3d) as having the most active anticancer activity, with slight differences in binding energy compared to other hybrids (3a and 3b). However, regarding the anti-coronavirus inhibitory effect, compounds 3a, 3b, 3c, and 3d exhibited moderate binding affinities to RNA polymerase.
This research is an In silico study; no humans or animals were enrolled in it. However, the ethics committee at the University of Baghdad, Iraq, gave us ethical approval numbers 243-2024.
The 1st author (May) contributed to the experimental design of the study, data analysis, methodology, and draft writing, providing access to research components, and the 2nd author (Jaafar) contributed to draft writing, revision, data analysis, and statistical analysis.
All data was placed in an online repository on the Zenodo website (DOI: doi.org/10.5281/zenodo.11469230).
Contained the following data:
These data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).
We thank the Department of Pharmaceutical Chemistry at the University of Baghdad, Iraq, for their great support.